This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Adams M.R., Marteau P.: On the safety of lactic acid bacteria from food. Int. J. Food Microbiol., 1995; 27: 263–264AdamsM.R.MarteauP.On the safety of lactic acid bacteria from foodInt. J. Food Microbiol.19952726326410.1016/0168-1605(95)00067-TSearch in Google Scholar
Azad A.K., Sarker M., Li T., Yin J.: Probiotic species in the modulation of gut microbiota: An overview. Biomed. Res. Int., 2018; 2018: 9478630AzadA.K.SarkerM.LiT.YinJ.Probiotic species in the modulation of gut microbiota: An overviewBiomed. Res. Int.20182018947863010.1155/2018/9478630Search in Google Scholar
Bartnicka A., Szachta P., Gałęcka M.: Faecal microbiota transplant – prospects and safety. Pomeranian J. Life Sci., 2015; 61: 282–286BartnickaA.SzachtaP.GałęckaM.Faecal microbiota transplant – prospects and safetyPomeranian J. Life Sci.20156128228610.21164/pomjlifesci.98Search in Google Scholar
Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., Nieuwenhuijs V.B., Bollen T.L., van Ramshorst B., Witteman B.J., Rosman C., Ploeg R.J., Brink M.A., Schaapherder A.F., Dejong C.H., et al.: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet, 2008; 371: 651–659BesselinkM.G.van SantvoortH.C.BuskensE.BoermeesterM.A.van GoorH.TimmermanH.M.NieuwenhuijsV.B.BollenT.L.van RamshorstB.WittemanB.J.RosmanC.PloegR.J.BrinkM.A.SchaapherderA.F.DejongC.H.Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trialLancet200837165165910.1016/S0140-6736(08)60207-XSearch in Google Scholar
Binek M.: Mikrobiom człowieka – zdrowie i choroba. Post. Mikrobiol., 2012; 51: 27–36BinekM.Mikrobiom człowieka – zdrowie i chorobaPost. Mikrobiol.2012512736Search in Google Scholar
Bischoff S.C., Escher J., Hébuterne X., Kłęk S., Krznaric Z., Schneider S., Shamir R., Stardelova K., Wierdsma N., Wiskin A.E., Forbes A.: ESPEN practical guideline: Clinical nutrition in inflammatory bowel disease. Clin. Nutrition, 2020; 39: 632–653BischoffS.C.EscherJ.HébuterneX.KłękS.KrznaricZ.SchneiderS.ShamirR.StardelovaK.WierdsmaN.WiskinA.E.ForbesA.ESPEN practical guideline: Clinical nutrition in inflammatory bowel diseaseClin. Nutrition20203963265310.1016/j.clnu.2019.11.00232029281Search in Google Scholar
Brown W.R.: Fecal microbiota transplantation in treating Clostridium difficile infection. J. Dig. Dis., 2014; 15: 405–408BrownW.R.Fecal microbiota transplantation in treating Clostridium difficile infectionJ. Dig. Dis.20141540540810.1111/1751-2980.1216024825534Search in Google Scholar
Charteris W.P., Kelly P.M., Morelli L., Collins J.K.: Antibiotic susceptibility of potentially probiotic Lactobacillus species. J. Food Prot., 1998; 61: 1636–1643CharterisW.P.KellyP.M.MorelliL.CollinsJ.K.Antibiotic susceptibility of potentially probiotic Lactobacillus speciesJ. Food Prot.1998611636164310.4315/0362-028X-61.12.1636Search in Google Scholar
Cichy W., Gałęcka M., Szachta P.: Probiotyki jako alternatywne rozwiązanie i wsparcie terapii tradycyjnych. Zakażenia, 2010; 6: 2–8CichyW.GałęckaM.SzachtaP.Probiotyki jako alternatywne rozwiązanie i wsparcie terapii tradycyjnychZakażenia2010628Search in Google Scholar
Cremon C., Barbaro M.R., Ventura M., Barbara G.: Pre- and probiotic overview. Curr. Opin. Pharmacol., 2018; 43: 87–92CremonC.BarbaroM.R.VenturaM.BarbaraG.Pre- and probiotic overviewCurr. Opin. Pharmacol.201843879210.1016/j.coph.2018.08.01030219638Search in Google Scholar
Curragh H.J., Collins M.A.: High levels of spontaneous drug resistance in Lactobacillus. J. Appl. Bacteriol., 1992; 73: 31–36CurraghH.J.CollinsM.A.High levels of spontaneous drug resistance in LactobacillusJ. Appl. Bacteriol.199273313610.1111/j.1365-2672.1992.tb04965.xSearch in Google Scholar
Dopuszczanie do obrotu suplementów diety. Najwyższa Izba Kontroli. https//www.nik.gov.pl/plik/id.13031,vp,15443.pdf. (18.12.2019)Dopuszczanie do obrotu suplementów dietyNajwyższa Izba Kontrolihttps//www.nik.gov.pl/plik/id.13031,vp,15443.pdf. (18.12.2019)Search in Google Scholar
Doron S., Snydman D.R.: Risk and safety of probiotics. Clin. Infect. Dis., 2015; 60, Suppl. 2: 129–134DoronS.SnydmanD.R.Risk and safety of probioticsClin. Infect. Dis.201560Suppl. 212913410.1093/cid/civ085449023025922398Search in Google Scholar
Fenster K., Freeburg B., Hollard C., Wong C., RønhaveLaursen R., Ouwehand A.C.: The production and delivery of probiotics: A review of a practical approach. Microorganisms, 2019; 7: 83FensterK.FreeburgB.HollardC.WongC.RønhaveLaursenR.OuwehandA.C.The production and delivery of probiotics: A review of a practical approachMicroorganisms201978310.3390/microorganisms7030083646306930884906Search in Google Scholar
Floch M.H., Walker W.A., Guandalini S., Hibberd P., Gorbach S., Surawicz C., Sanders M.E., Garcia-Tsao G., Quigley E.M.M., Isolauri E., Fedorak R.N., Dieleman L.A.: Recommendations for probiotic use – 2008. J. Clin. Gastroenterol., 2008; 42, Suppl. 2: 104–108FlochM.H.WalkerW.A.GuandaliniS.HibberdP.GorbachS.SurawiczC.SandersM.E.Garcia-TsaoG.QuigleyE.M.M.IsolauriE.FedorakR.N.DielemanL.A.Recommendations for probiotic use – 2008J. Clin. Gastroenterol200842Suppl. 210410810.1097/MCG.0b013e31816b903f18542033Search in Google Scholar
Floch M.H., Walker W.A., Sanders M.E., Nieuwdorp M., Kim A.S., Brenner D.A., Qamar A.A., Miloh T.A., Guarino A., Guslandi M., Dieleman L.A., Ringel Y., Quigley E.M., Brandt L.J.: Recommendations for probiotic use – 2015 update: Proceedings and consensus opinion. J. Clin. Gastroenterol., 2015; 49, Suppl. 1: 69–73FlochM.H.WalkerW.A.SandersM.E.NieuwdorpM.KimA.S.BrennerD.A.QamarA.A.MilohT.A.GuarinoA.GuslandiM.DielemanL.A.RingelY.QuigleyE.M.BrandtL.J.Recommendations for probiotic use – 2015 update: Proceedings and consensus opinionJ. Clin. Gastroenterol201549Suppl. 1697310.1097/MCG.000000000000042026447969Search in Google Scholar
Francino M.P.: Antibiotics and the human gut microbiome: dysbioses and accumulation of resistances. Front. Microbiol., 2016; 6: 1543FrancinoM.P.Antibiotics and the human gut microbiome: dysbioses and accumulation of resistancesFront. Microbiol.20166154310.3389/fmicb.2015.01543470986126793178Search in Google Scholar
Fric P.: Probiotics and prebiotics – renaissance of a therapeutic principle. Open Med., 2007; 2: 237–270FricP.Probiotics and prebiotics – renaissance of a therapeutic principleOpen Med.2007223727010.2478/s11536-007-0031-5Search in Google Scholar
Gibson G.R., Rastall R.A., Roberfroid M.B.: Prebiotics. In: Colonic Microbiota, Nutrition and Health. ed.: G.R. Gibson, M.B. Roberfroid. Springer Netherlands, Dordrecht 1999, 101–124GibsonG.R.RastallR.A.RoberfroidM.B.PrebioticsIn:Colonic Microbiota, Nutrition and Healthed.:GibsonG.R.RoberfroidM.B.SpringerNetherlands, Dordrecht199910112410.1007/978-94-017-1079-4_7Search in Google Scholar
Główny Inspektorat Sanitarny – Gov.pl. https//www.gis.gov.pl/o-nas/aktualności/480-suplementy-kontrola-nik-i-uwagi-gis (20.01.2020)Główny Inspektorat SanitarnyGov.pl. https//www.gis.gov.pl/o-nas/aktualności/480-suplementy-kontrola-nik-i-uwagi-gis (20.01.2020)Search in Google Scholar
Gomes D.O., de Morais M.B.: Gut microbiota and the use of probiotics in constipation in children and adolescents: systematic review. Rev. Paul. Pediatr., 2019; 38: e2018123GomesD.O.de MoraisM.B.Gut microbiota and the use of probiotics in constipation in children and adolescents: systematic reviewRev. Paul. Pediatr.201938e201812310.1590/1984-0462/2020/38/2018123690925731778407Search in Google Scholar
Guarino A., Ashkenazi S., Gendrel D., Lo Vecchio A., Shamir R., Szajewska H., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition, European Society for Pediatric Infectious Diseases: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J. Pediatr. Gastroenterol. Nutr., 2014; 59: 132–152GuarinoA.AshkenaziS.GendrelD.Lo VecchioA.ShamirR.SzajewskaH.European Society for Pediatric Gastroenterology, Hepatology, and Nutrition, European Society for Pediatric Infectious DiseasesEuropean Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014J. Pediatr. Gastroenterol. Nutr.20145913215210.1097/MPG.000000000000037524739189Search in Google Scholar
Guidelines for the Evaluation of Probiotics in Food. Joint FAO/WHO Working Group Report on Draging Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May 1, 2002 (20.11.2019)Guidelines for the Evaluation of Probiotics in FoodJoint FAO/WHO Working Group Report on Draging Guidelines for the Evaluation of Probiotics in FoodLondon, Ontario, CanadaApril30andMay12002(20.11.2019)Search in Google Scholar
Hamilton-Miller J.M., Shah S., Winkler J.T.: Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr., 1999; 2: 223–229Hamilton-MillerJ.M.ShahS.WinklerJ.T.Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganismsPublic Health Nutr.1999222322910.1017/S136898009900028210447251Search in Google Scholar
Hoa N.T., Baccigalupi L., Huxham A., Smertenko A., Van P.H., Ammendola S., Ricca E., Cutting A.S.: Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl. Environ. Microbiol., 2000; 66: 5241–5247HoaN.T.BaccigalupiL.HuxhamA.SmertenkoA.VanP.H.AmmendolaS.RiccaE.CuttingA.S.Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disordersAppl. Environ. Microbiol.2000665241524710.1128/AEM.66.12.5241-5247.20009245111097897Search in Google Scholar
Holmes E., Li J.V., Athanasiou T., Ashrafian H., Nicholson J.K.: Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends Microbiol., 2011; 19: 349–359HolmesE.LiJ.V.AthanasiouT.AshrafianH.NicholsonJ.K.Understanding the role of gut microbiome-host metabolic signal disruption in health and diseaseTrends Microbiol.20111934935910.1016/j.tim.2011.05.006Search in Google Scholar
Holzapfel W.H., Haberer P., Snel J., Schillinger U., Huis in’t Veld J.H.: Overview of gut flora and probiotics. Int. J. Food Microbiol., 1998; 41: 85–101HolzapfelW.H.HabererP.SnelJ.SchillingerU.Huis in’t VeldJ.H.Overview of gut flora and probioticsInt. J. Food Microbiol.1998418510110.1016/S0168-1605(98)00044-0Search in Google Scholar
Jach M., Łoś R., Maj M., Malm A.: Probiotyki – aspekty funkcjonalne i technologiczne. Post. Mikrobiol., 2013; 52: 161–170JachM.ŁośR.MajM.MalmA.Probiotyki – aspekty funkcjonalne i technologicznePost. Mikrobiol.201352161170Search in Google Scholar
Jernberg C., Löfmark S., Edlund C., Jansson J.K.: Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J, 2007; 1: 56–66JernbergC.LöfmarkS.EdlundC.JanssonJ.K.Long-term ecological impacts of antibiotic administration on the human intestinal microbiotaISME J20071566610.1038/ismej.2007.318043614Search in Google Scholar
Kamińska E.: Skuteczność i bezpieczeństwo stosowania probiotyków na podstawie badań klinicznych przeprowadzonych u dzieci. Med. Wieku Rozwoj., 2012; 16: 240–251KamińskaE.Skuteczność i bezpieczeństwo stosowania probiotyków na podstawie badań klinicznych przeprowadzonych u dzieciMed. Wieku Rozwoj.201216240251Search in Google Scholar
Kaźmierska A.: Probiotyki – recepta na zdrowie? Kosmos, 2014; 63: 455–472KaźmierskaA.Probiotyki – recepta na zdrowie?Kosmos201463455472Search in Google Scholar
Kim H.J., Vazquez Roque M.I., Camilleri M., Stephens D., Burton D.D., Baxter K., Thomforde G., Zinsmeister A.R.: A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol. Motil., 2005; 17: 687–696KimH.J.Vazquez RoqueM.I.CamilleriM.StephensD.BurtonD.D.BaxterK.ThomfordeG.ZinsmeisterA.R.A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloatingNeurogastroenterol. Motil.20051768769610.1111/j.1365-2982.2005.00695.x16185307Search in Google Scholar
Kothari D., Patel S., Kim S.K.: Probiotic supplements might not be universally-effective and safe: A review. Biomed. Pharmacother., 2019; 111: 537–547KothariD.PatelS.KimS.K.Probiotic supplements might not be universally-effective and safe: A reviewBiomed. Pharmacother.201911153754710.1016/j.biopha.2018.12.10430597307Search in Google Scholar
Krasnowska Y., Sikora T.: Suplementy diety a bezpieczeństwo konsumenta. Żywn. Nauka Technol. Jakość, 2011; 77: 5–23KrasnowskaY.SikoraT.Suplementy diety a bezpieczeństwo konsumentaŻywn. Nauka Technol. Jakość201177523Search in Google Scholar
Kubiszewska I., Januszewska M., Rybka J., Gackowska L.: Bakterie kwasu mlekowego i zdrowie: czy probiotyki są bezpieczne dla człowieka? Postępy Hig. Med. Dośw., 2014; 68: 1325–1334KubiszewskaI.JanuszewskaM.RybkaJ.GackowskaL.Bakterie kwasu mlekowego i zdrowie: czy probiotyki są bezpieczne dla człowieka?Postępy Hig. Med. Dośw.2014681325133410.5604/17322693.112912025404621Search in Google Scholar
Kuśmierska A., Fol M.: Właściwości immunomodulacyjne i terapeutyczne drobnoustrojów probiotycznych. Probl. Hig. Epidemiol, 2014; 95: 529–540KuśmierskaA.FolM.Właściwości immunomodulacyjne i terapeutyczne drobnoustrojów probiotycznychProbl. Hig. Epidemiol201495529540Search in Google Scholar
La Fata G., Weber P., Mohajeri M.H.: Probiotics and the Gut Immune System: Indirect Regulation. Probiotics Antimicrob. Proteins, 2018; 10: 11–21La FataG.WeberP.MohajeriM.H.Probiotics and the Gut Immune System: Indirect RegulationProbiotics Antimicrob. Proteins201810112110.1007/s12602-017-9322-6580139728861741Search in Google Scholar
Lloyd-Price J., Abu-Ali G., Huttenhower C.: The healthy human microbiome. Genome Med, 2016; 8: 51Lloyd-PriceJ.Abu-AliG.HuttenhowerC.The healthy human microbiomeGenome Med201685110.1186/s13073-016-0307-y484887027122046Search in Google Scholar
Löfmark S., Jernberg C., Jansson J.K., Edlund C.: Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J. Antimicrob. Chemother., 2006; 58: 1160–1167LöfmarkS.JernbergC.JanssonJ.K.EdlundC.Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genesJ. Antimicrob. Chemother.2006581160116710.1093/jac/dkl42017046967Search in Google Scholar
López-Moreno A., Aguilera M.: Probiotics dietary supplementation for modulating endocrine and fertility microbiota dysbiosis. Nutrients, 2020; 12: 757López-MorenoA.AguileraM.Probiotics dietary supplementation for modulating endocrine and fertility microbiota dysbiosisNutrients20201275710.3390/nu12030757714645132182980Search in Google Scholar
Lutyńska A., Augustynowicz E., Wiatrzyk A.: Problemy stosowania suplementów diety zawierających probiotyki. Probl. Hig. Epidemiol., 2012; 93: 493–498LutyńskaA.AugustynowiczE.WiatrzykA.Problemy stosowania suplementów diety zawierających probiotykiProbl. Hig. Epidemiol.201293493498Search in Google Scholar
Malla M.A., Dubey A., Kumar A., Yadav S., Hashem A., Abd Allah E.F.: Exploring the human microbiome: The potential future role of next–generation sequencing in disease diagnosis and treatment. Front. Immunol., 2019; 9: 2868MallaM.A.DubeyA.KumarA.YadavS.HashemA.Abd AllahE.F.Exploring the human microbiome: The potential future role of next–generation sequencing in disease diagnosis and treatmentFront. Immunol.20199286810.3389/fimmu.2018.02868633029630666248Search in Google Scholar
Manzanares W., Lemieux M., Langlois P.L., Wischmeyer P.E.: Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit. Care, 2016; 19: 262ManzanaresW.LemieuxM.LangloisP.L.WischmeyerP.E.Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysisCrit. Care20161926210.1186/s13054-016-1434-y499101027538711Search in Google Scholar
Marcinkiewicz J., Ciszek M., Bobek M., Strus M., Heczko P.B., Kurnyta M., Biedroń R., Chmielarczyk A.: Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int. J. Exp. Pathol., 2007; 88: 155–164MarcinkiewiczJ.CiszekM.BobekM.StrusM.HeczkoP.B.KurnytaM.BiedrońR.ChmielarczykA.Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteriaInt. J. Exp. Pathol.20078815516410.1111/j.1365-2613.2007.00530.x251729917504445Search in Google Scholar
McDonald D., Ackermann G., Khailova L., Baird C., Heyland D., Kozar R., Lemieux M., Derenski K., King J., Vis-Kampen C., Knight R., Wischmeyer P.E.: Extreme dysbiosis of the microbiome in critical illness. mSphere, 2016; 1: e00199–00216McDonaldD.AckermannG.KhailovaL.BairdC.HeylandD.KozarR.LemieuxM.DerenskiK.KingJ.Vis-KampenC.KnightR.WischmeyerP.E.Extreme dysbiosis of the microbiome in critical illnessmSphere20161e001990021610.1128/mSphere.00199-16500743127602409Search in Google Scholar
Miecznikow E.: O naturze ludzkiej. Zarys filozofii optymistycznej. Translated by F. Wermiński. Warszawa: Biblioteka Naukowa 1907MiecznikowE.O naturze ludzkiej. Zarys filozofii optymistycznejTranslated byWermińskiF.WarszawaBiblioteka Naukowa1907Search in Google Scholar
Miele E., Pascarella F., Giannetti E., Quaglietta L., Baldassano R.N., Staiano A.: Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am. J. Gastroenterol., 2009; 104: 437–443MieleE.PascarellaF.GiannettiE.QuagliettaL.BaldassanoR.N.StaianoA.Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitisAm. J. Gastroenterol.200910443744310.1038/ajg.2008.11819174792Search in Google Scholar
Mojka K.: Probiotyki, prebiotyki i synbiotyki – charakterystyka i funkcje. Probl. Hig. Epidemiol., 2014; 95: 541–549MojkaK.Probiotyki, prebiotyki i synbiotyki – charakterystyka i funkcjeProbl. Hig. Epidemiol.201495541549Search in Google Scholar
Monteagudo-Mera A., Rastall R.A., Gibson G.R., Charalampopoulos D., Chatzifragkou A.: Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl. Microbiol. Biotechnol., 2019; 103: 6463–6472Monteagudo-MeraA.RastallR.A.GibsonG.R.CharalampopoulosD.ChatzifragkouA.Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human healthAppl. Microbiol. Biotechnol.20191036463647210.1007/s00253-019-09978-7666740631267231Search in Google Scholar
Mundula T., Ricci F., Barbetta B., Baccini M., Amedei A.: Effect of probiotics on oral candidiasis: A systematic review and meta-analysis. Nutrients, 2019; 11: 2449MundulaT.RicciF.BarbettaB.BacciniM.AmedeiA.Effect of probiotics on oral candidiasis: A systematic review and meta-analysisNutrients201911244910.3390/nu11102449683601031615039Search in Google Scholar
Najwyższa Izba Kontroli. https://www.nik.gov.pl/aktualnosci/nik-o-dopuszczaniu-do-obrotu-suplementow-diety.html (27.4.2020)Najwyższa Izba Kontrolihttps://www.nik.gov.pl/aktualnosci/nik-o-dopuszczaniu-do-obrotu-suplementow-diety.html (27.4.2020)Search in Google Scholar
Natural Health Products Ingredients Database. https://www.webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_probiotics_english.pdf. (15.01.2020)Natural Health Products Ingredients Databasehttps://www.webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_probiotics_english.pdf. (15.01.2020)Search in Google Scholar
Nowak A., Śliżewska K., Libudzisz Z: Probiotyki – historia i mechanizmy działania. Żywn. Nauka Technol. Jakość, 2010; 4: 5–19NowakA.ŚliżewskaK.LibudziszZ.Probiotyki – historia i mechanizmy działaniaŻywn. Nauka Technol. Jakość20104519Search in Google Scholar
Olszewska J., Jagusztyn-Krynicka E.K.: Human Microbiome Project – mikroflora jelit oraz jej wpływ na fizjologię i zdrowie człowieka. Post. Mikrobiol., 2012; 51: 243–256OlszewskaJ.Jagusztyn-KrynickaE.K.Human Microbiome Project – mikroflora jelit oraz jej wpływ na fizjologię i zdrowie człowiekaPost. Mikrobiol.201251243256Search in Google Scholar
O’Toole P.W., Marchesi J.R., Hill C.: Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol., 2017; 2: 17057O’TooleP.W.MarchesiJ.R.HillC.Next-generation probiotics: the spectrum from probiotics to live biotherapeuticsNat. Microbiol.201721705710.1038/nmicrobiol.2017.5728440276Search in Google Scholar
Ouwehand A.C.: A review of dose-responses of probiotics in human studies. Benef. Microbes, 2017; 8: 143–151OuwehandA.C.A review of dose-responses of probiotics in human studiesBenef. Microbes2017814315110.3920/BM2016.014028008787Search in Google Scholar
Panasiuk A: Mikrobiota przewodu pokarmowego. Wydawnictwo Lekarskie PZWL, Warszawa 2019PanasiukAMikrobiota przewodu pokarmowegoWydawnictwo Lekarskie PZWLWarszawa2019Search in Google Scholar
Pattani R., Palda V.A., Hwang S.W., Shah P.S.: Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: Systematic review and meta-analysis. Open Med., 2013; 7: 56–67PattaniR.PaldaV.A.HwangS.W.ShahP.S.Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: Systematic review and meta-analysisOpen Med.201375667Search in Google Scholar
Renter G.: Present and future of probiotics in Germany and in Central Europe. Biosci. Microflora, 1997; 16: 43–51RenterG.Present and future of probiotics in Germany and in Central EuropeBiosci. Microflora199716435110.12938/bifidus1996.16.43Search in Google Scholar
Rudzki L., Szulc A.: Wpływ jelitowej flory bakteryjnej na ośrodkowy układ nerwowy i jej potencjalne znaczenie w leczeniu zaburzeń psychicznych. Farmakoter. Psych. Neurol., 2013; 2: 69–77RudzkiL.SzulcA.Wpływ jelitowej flory bakteryjnej na ośrodkowy układ nerwowy i jej potencjalne znaczenie w leczeniu zaburzeń psychicznychFarmakoter. Psych. Neurol.201326977Search in Google Scholar
Ruszkowski J., Szewczyk A., Witkowski J.M.: An overview of oral prebiotics, probiotics, synbiotics and post-biotic available on the Polish pharmacy market. Farm. Pol., 2018; 74: 114–122RuszkowskiJ.SzewczykA.WitkowskiJ.M.An overview of oral prebiotics, probiotics, synbiotics and post-biotic available on the Polish pharmacy marketFarm. Pol.20187411412210.32383/farmpol/119464Search in Google Scholar
Salminen S., von Wright A., Morelli L., Marteau P., Brassart D., de Vos W.M., Fondén R., Saxelin M., Collins K., Mogensen G., Birkeland S.E., Mattila-Sandholm T.: Demonstration of safety of probiotics – a review. Int. J. Food Microbiol., 1998; 44: 93–106SalminenS.von WrightA.MorelliL.MarteauP.BrassartD.de VosW.M.FondénR.SaxelinM.CollinsK.MogensenG.BirkelandS.E.Mattila-SandholmT.Demonstration of safety of probiotics – a reviewInt. J. Food Microbiol.1998449310610.1016/S0168-1605(98)00128-7Search in Google Scholar
Saxelin M., Lassig A., Karjalainen H., Tynkkynen S., Surakka A., Vapaatalo H., Järvenpää S., Korpela R., Mutanen M., Hatakka K.: Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int. J. Food Microbiol., 2010; 144: 293–300SaxelinM.LassigA.KarjalainenH.TynkkynenS.SurakkaA.VapaataloH.JärvenpääS.KorpelaR.MutanenM.HatakkaK.Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheeseInt. J. Food Microbiol.201014429330010.1016/j.ijfoodmicro.2010.10.009Search in Google Scholar
Schrezenmeir J., de Vrese M.: Probiotics, prebiotics, and synbiotics – approaching a definition. Am. J. Clin. Nutr., 2001; 73: 361–364SchrezenmeirJ.de VreseM.Probiotics, prebiotics, and synbiotics – approaching a definitionAm. J. Clin. Nutr.20017336136410.1093/ajcn/73.2.361sSearch in Google Scholar
Suez J., Zmora N., Zilberman-Schapira G., Mor U., Dori-Bachash M., Bashiardes S., Zur M., Regev-Lehavi D., Ben-Zeev Brik R., Federici S., Horn M., Cohen Y., Moor A.E., Zeevi D., Korem T., et al.: Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell, 2018; 174: 1406–1423SuezJ.ZmoraN.Zilberman-SchapiraG.MorU.Dori-BachashM.BashiardesS.ZurM.Regev-LehaviD.Ben-Zeev BrikR.FedericiS.HornM.CohenY.MoorA.E.ZeeviD.KoremT.Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMTCell20181741406142310.1016/j.cell.2018.08.047Search in Google Scholar
Summary of Product Characteristics (Charakterystyka Produktu Leczniczego) Enterol. https://www.pub.rejestrymedyczne.csioz.gov.pl/Pobieranie.ashx?type=7890-c (15.11.2019)Summary of Product Characteristics (Charakterystyka Produktu Leczniczego) Enterolhttps://www.pub.rejestrymedyczne.csioz.gov.pl/Pobieranie.ashx?type=7890-c (15.11.2019)Search in Google Scholar
Szachta P., Pazgrat M., Cichy W., Muszyński Z., Ignyś I.: Szczepy probiotyczne –perspektywy i bezpieczeństwo. Gastroenterol. Pol., 2009; 16: 37–41SzachtaP.PazgratM.CichyW.MuszyńskiZ.IgnyśI.Szczepy probiotyczne –perspektywy i bezpieczeństwoGastroenterol. Pol.2009163741Search in Google Scholar
Szajewska H.: Praktyczne zastosowanie probiotyków. Gastroenterol. Klin., 2014; 6: 16–23SzajewskaH.Praktyczne zastosowanie probiotykówGastroenterol. Klin.201461623Search in Google Scholar
Szajewska H.: Probiotyki w Polsce – kiedy, jakie i dlaczego? Gastroenterol. Klin., 2010; 2: 1–9SzajewskaH.Probiotyki w Polsce – kiedy, jakie i dlaczego?Gastroenterol. Klin.2010219Search in Google Scholar
Szajewska H.: Probiotyki w gastroenterologii – aktualny stan wiedzy. Gastroenterol. Klin., 2015; 7: 20–26SzajewskaH.Probiotyki w gastroenterologii – aktualny stan wiedzyGastroenterol. Klin.201572026Search in Google Scholar
Szajewska H., Canani R.B., Guarino A., Hojsak I., Indrio F., Kolacek S., Orel R., Shamir R., Vandenplas Y., van Goudoever J.B., Weizman Z., ESPGHAN Working Group for ProbioticsPrebiotics: Probiotics for the prevention of antibiotic-associated diarrhea in children. J. Pediatr. Gastroenterol. Nutr., 2016; 62: 495–506SzajewskaH.CananiR.B.GuarinoA.HojsakI.IndrioF.KolacekS.OrelR.ShamirR.VandenplasY.van GoudoeverJ.B.WeizmanZ.ESPGHAN Working Group for ProbioticsPrebioticsProbiotics for the prevention of antibiotic-associated diarrhea in childrenJ. Pediatr. Gastroenterol. Nutr.20166249550610.1097/MPG.0000000000001081Search in Google Scholar
Szajewska H., Guarino A., Hojsak I., Indrio F., Kolacek S., Shamir R., Vandenplas Y., Weizman Z., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition: Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J. Pediatr. Gastroenterol. Nutr., 2014; 58: 531–539SzajewskaH.GuarinoA.HojsakI.IndrioF.KolacekS.ShamirR.VandenplasY.WeizmanZ.European Society for Pediatric Gastroenterology, Hepatology, and NutritionUse of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and PrebioticsJ. Pediatr. Gastroenterol. Nutr.20145853153910.1097/MPG.0000000000000320Search in Google Scholar
Szajewska H., Gyrczuk E., Horvath A.: Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J. Pediatr., 2013; 162: 257–262SzajewskaH.GyrczukE.HorvathA.Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trialJ. Pediatr.201316225726210.1016/j.jpeds.2012.08.004Search in Google Scholar
Szajewska H., Kołodziej M., Gieruszczak-Białek D., Skórka A., Ruszczyński M., Shamir R.: Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children – a 2019 update. Aliment. Pharmacol. Ther., 2019; 49: 1376–1384SzajewskaH.KołodziejM.Gieruszczak-BiałekD.SkórkaA.RuszczyńskiM.ShamirR.Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children – a 2019 updateAliment. Pharmacol. Ther.2019491376138410.1111/apt.15267Search in Google Scholar
Szymański H., Chmielarczyk A., Strus M., Pejcz J., Jawień M., Kochan P., Heczko P.B.: Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children. Dig. Liver Dis., 2006; 38, Suppl. 2: 274–276SzymańskiH.ChmielarczykA.StrusM.PejczJ.JawieńM.KochanP.HeczkoP.B.Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in childrenDig. Liver Dis.200638Suppl. 227427610.1016/S1590-8658(07)60009-7Search in Google Scholar
The law on food safety and nutrition of 25 August 2006. Dz. U. 2006r. Nr 171, poz.1225; (09.12.2019)The law on food safety and nutrition of 25 August 2006Dz. U. 2006r. Nr 171, poz.1225; (09.12.2019)Search in Google Scholar
Tokarz-Deptuła B., Śliwa-Dominiak J., Adamiak M., Deptuła W.: Probiotyki a wybrane schorzenia u ludzi. Post. Mikrobiol., 2015; 54: 133–140Tokarz-DeptułaB.Śliwa-DominiakJ.AdamiakM.DeptułaW.Probiotyki a wybrane schorzenia u ludziPost. Mikrobiol.201554133140Search in Google Scholar
Tompkins T.A., Mainville I., Arcand Y.: The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract. Benef. Microbes, 2011; 2: 295–303TompkinsT.A.MainvilleI.ArcandY.The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tractBenef. Microbes2011229530310.3920/BM2011.002222146689Search in Google Scholar
Tsai Y.L., Lin T.L., Chang C.J., Wu T.R., Lai W.F., Lu C.C., Lai H.C.: Probiotics, prebiotics and amelioration of diseases. J. Biomed. Sci., 2019; 26: 3TsaiY.L.LinT.L.ChangC.J.WuT.R.LaiW.F.LuC.C.LaiH.C.Probiotics, prebiotics and amelioration of diseasesJ. Biomed. Sci.201926310.1186/s12929-018-0493-6632057230609922Search in Google Scholar
Wasilewska E., Złotkowska D., Pijagin M.E.: The role of intestinal microflora and probiotic bacteria in prophylactic and development of colorectal cancer. Postępy Hig. Med. Dośw., 2013; 67: 837–847WasilewskaE.ZłotkowskaD.PijaginM.E.The role of intestinal microflora and probiotic bacteria in prophylactic and development of colorectal cancerPostępy Hig. Med. Dośw.20136783784710.5604/17322693.106184724018449Search in Google Scholar
Whorwell P.J., Altringer L., Morel J., Bond Y., Charbonneau D., O’Mahony L., Kiely B., Shanahan F., Quigley E.M.: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am. J. Gastroenterol., 2006; 101: 1581–1590WhorwellP.J.AltringerL.MorelJ.BondY.CharbonneauD.O’MahonyL.KielyB.ShanahanF.QuigleyE.M.Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndromeAm. J. Gastroenterol.20061011581159010.1111/j.1572-0241.2006.00734.x16863564Search in Google Scholar
World Gastroenterology Organisation Global Guidelines. Probiotics and prebiotics. https://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english (27.4.2020)World Gastroenterology Organisation Global GuidelinesProbiotics and prebioticshttps://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probiotics-and-prebiotics-english (27.4.2020)Search in Google Scholar
Yan F., Polk D.B.: Probiotics and immune health. Curr. Opin. Gastroenterol., 2011; 27: 496–501YanF.PolkD.B.Probiotics and immune healthCurr. Opin. Gastroenterol.20112749650110.1097/MOG.0b013e32834baa4d400699321897224Search in Google Scholar
Yoon M.Y., Yoon S.S.: Disruption of the gut ecosystem by antibiotics. Yonsei Med. J., 2018; 59: 4–12YoonM.Y.YoonS.S.Disruption of the gut ecosystem by antibioticsYonsei Med. J.20185941210.3349/ymj.2018.59.1.4572536229214770Search in Google Scholar